Agios Pharmaceuticals, Inc. (AGIO)
34.19
+0.36
(+1.06%)
USD |
NASDAQ |
Apr 01, 16:00
34.19
0.00 (0.00%)
Pre-Market: 20:00
Agios Pharmaceuticals Research and Development Expense (TTM) : 334.36M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.320B |
| Catalyst Pharmaceuticals, Inc. | 12.71M |
| Karyopharm Therapeutics, Inc. | 125.32M |
| Spyre Therapeutics, Inc. | 171.65M |
| Tyra Biosciences, Inc. | 102.38M |